VitalPath today announced it appointed Andrew Holman as its new CEO.
Holman brings more than 28 years of medical device experience to the complex catheter solution company. He has held numerous leadership roles at contract manufacturers and OEMs. Most recently, he was the chief commercial officer at Prytime Medical Devices, where he helped bring a balloon catheter for the trauma space to market.
“Andrew’s catheter experience in both the OEM and contract manufacturing spaces will serve VitalPath extremely well,” Aliya Khaydarova, a VitalPath board member and managing principal at Inverness Graham, said in a news release. “Andrew brings the kind of customer-first mentality that will benefit VitalPath customers immensely. The combination of this customer-centric leadership and our leading engineering, design-center, and manufacturing cap…